MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.jtho.2022.07.007

Медицинская библиотека · Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer · 2022

Cytisine Therapy Improved Smoking Cessation in the Randomized Screening and Multiple Intervention on Lung Epidemics Lung Cancer Screening Trial.

Pastorino Ugo, Ladisa Vito, Trussardo Sara, Sabia Federica, Rolli Luigi, Valsecchi Camilla, Ledda Roberta E, Milanese Gianluca, Suatoni Paola, Boeri Mattia, Sozzi Gabriella, Marchianò Alfonso, Munarini Elena, Boffi Roberto, Gallus Silvano, Apolone Giovanni

СтатьяРандомизированное исследованиеПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

INTRODUCTION

Cytisine, a partial agonist-binding nicotine acetylcholine receptor, is a promising cessation intervention. We conducted a single-center, randomized, controlled trial (RCT) in Italy to assess the efficacy and tolerability of cytisine as a smoking cessation therapy among lung cancer screening participants.

METHODS

From July 2019 to March 2020, the Screening and Multiple Intervention on Lung Epidemics RCT enrolled 869 current heavy tobacco users in a low-dose computed tomography screening program, with a randomized comparison of pharmacologic intervention with cytisine plus counseling (N = 470) versus counseling alone (N = 399). The primary outcome was continuous smoking abstinence at 12 months, biochemically verified through carbon monoxide measurement.

RESULTS

At the 12-month follow-up, the quit rate was 32.1% (151 participants) in the intervention arm and 7.3% (29 participants) in the control arm. The adjusted OR of continuous abstinence was 7.2 (95% confidence interval: 4.6-11.2). Self-reported adverse events occurred more frequently in the intervention arm (399 events among 196 participants) than in the control arm (230 events among 133 participants, p < 0.01). The most common adverse events were gastrointestinal symptoms, comprising abdominal swelling, gastritis, and constipation.

CONCLUSIONS

The efficacy and safety observed in the Screening and Multiple Intervention on Lung Epidemics RCT indicate that cytisine, a very low-cost medication, is a useful treatment option for smoking cessation and a feasible strategy to improve low-dose computed tomography screening outcomes with a potential benefit for all-cause mortality.

Для цитирования: Pastorino Ugo, Ladisa Vito, Trussardo Sara, Sabia Federica, Rolli Luigi, Valsecchi Camilla, Ledda Roberta E, Milanese Gianluca, Suatoni Paola, Boeri Mattia, Sozzi Gabriella, Marchianò Alfonso, Munarini Elena, Boffi Roberto, Gallus Silvano, Apolone Giovanni. Cytisine Therapy Improved Smoking Cessation in the Randomized Screening and Multiple Intervention on Lung Epidemics Lung Cancer Screening Trial.. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 2022. DOI: 10.1016/j.jtho.2022.07.007.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.